RBA Wealth Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6.8M | Sell |
63,308
-3,512
| -5% | -$377K | 2.53% | 9 |
|
2025
Q1 | $6.74M | Sell |
66,820
-583
| -0.9% | -$58.8K | 2.67% | 7 |
|
2024
Q4 | $6.02M | Sell |
67,403
-1,053
| -2% | -$94.1K | 2.29% | 10 |
|
2024
Q3 | $5.74M | Buy |
68,456
+1,210
| +2% | +$101K | 2.21% | 14 |
|
2024
Q2 | $5.18M | Sell |
67,246
-2,217
| -3% | -$171K | 2.08% | 18 |
|
2024
Q1 | $4.76M | Sell |
69,463
-1,220
| -2% | -$83.6K | 1.93% | 23 |
|
2023
Q4 | $4.09M | Sell |
70,683
-371
| -0.5% | -$21.4K | 1.78% | 29 |
|
2023
Q3 | $3.75M | Buy |
71,054
+936
| +1% | +$49.4K | 1.81% | 26 |
|
2023
Q2 | $3.79M | Buy |
70,118
+685
| +1% | +$37.1K | 1.77% | 28 |
|
2023
Q1 | $3.47M | Buy |
69,433
+2,302
| +3% | +$115K | 1.73% | 32 |
|
2022
Q4 | $3.11M | Buy |
67,131
+2,521
| +4% | +$117K | 1.63% | 32 |
|
2022
Q3 | $2.5M | Buy |
64,610
+923
| +1% | +$35.7K | 1.44% | 38 |
|
2022
Q2 | $2.37M | Buy |
63,687
+2,541
| +4% | +$94.7K | 1.32% | 39 |
|
2022
Q1 | $2.71M | Buy |
61,146
+5,950
| +11% | +$264K | 1.3% | 38 |
|
2021
Q4 | $2.35M | Buy |
55,196
+9,537
| +21% | +$405K | 1.11% | 42 |
|
2021
Q3 | $1.98M | Buy |
45,659
+1,696
| +4% | +$73.6K | 4.78% | 9 |
|
2021
Q2 | $1.88M | Buy |
43,963
+995
| +2% | +$42.5K | 3.99% | 10 |
|
2021
Q1 | $1.66M | Buy |
42,968
+3,128
| +8% | +$121K | 1.41% | 30 |
|
2020
Q4 | $1.43M | Buy |
39,840
+5,996
| +18% | +$216K | 0.86% | 50 |
|
2020
Q3 | $1.29M | Buy |
33,844
+3,971
| +13% | +$152K | 0.87% | 49 |
|
2020
Q2 | $1.05M | Buy |
29,873
+3,719
| +14% | +$131K | 0.76% | 49 |
|
2020
Q1 | $853K | Buy |
26,154
+10,377
| +66% | +$338K | 0.74% | 48 |
|
2019
Q4 | $712K | Buy |
15,777
+3,411
| +28% | +$154K | 0.49% | 52 |
|
2019
Q3 | $503K | Buy |
12,366
+6,520
| +112% | +$265K | 0.38% | 56 |
|
2019
Q2 | $251K | Buy |
+5,846
| New | +$251K | 0.19% | 75 |
|